Cargando…

T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study

BACKGROUND: Preoperative differentiation between benign and borderline epithelial ovarian tumors (EOTs) is challenging and can significantly impact clinical decision making. The purpose was to investigate whether radiomics based on T2-weighted MRI can discriminate between benign and borderline EOTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Mingxiang, Zhang, Yu, Bai, Genji, Ding, Cong, Xu, Haimin, Dai, Yao, Chen, Shuangqing, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363551/
https://www.ncbi.nlm.nih.gov/pubmed/35943620
http://dx.doi.org/10.1186/s13244-022-01264-x
_version_ 1784764949633957888
author Wei, Mingxiang
Zhang, Yu
Bai, Genji
Ding, Cong
Xu, Haimin
Dai, Yao
Chen, Shuangqing
Wang, Hong
author_facet Wei, Mingxiang
Zhang, Yu
Bai, Genji
Ding, Cong
Xu, Haimin
Dai, Yao
Chen, Shuangqing
Wang, Hong
author_sort Wei, Mingxiang
collection PubMed
description BACKGROUND: Preoperative differentiation between benign and borderline epithelial ovarian tumors (EOTs) is challenging and can significantly impact clinical decision making. The purpose was to investigate whether radiomics based on T2-weighted MRI can discriminate between benign and borderline EOTs preoperatively. METHODS: A total of 417 patients (309, 78, and 30 samples in the training and internal and external validation sets) with pathologically proven benign and borderline EOTs were included in this multicenter study. In total, 1130 radiomics features were extracted from manually delineated tumor volumes of interest on images. The following three different models were constructed and evaluated: radiomics features only (radiomics model); clinical and radiological characteristics only (clinic-radiological model); and a combination of them all (combined model). The diagnostic performances of models were assessed using receiver operating characteristic (ROC) analysis, and area under the ROC curves (AUCs) were compared using the DeLong test. RESULTS: The best machine learning algorithm to distinguish borderline from benign EOTs was the logistic regression. The combined model achieved the best performance in discriminating between benign and borderline EOTs, with an AUC of 0.86 ± 0.07. The radiomics model showed a moderate AUC of 0.82 ± 0.07, outperforming the clinic-radiological model (AUC of 0.79 ± 0.06). In the external validation set, the combined model performed significantly better than the clinic-radiological model (AUCs of 0.86 vs. 0.63, p = 0.021 [DeLong test]). CONCLUSIONS: Radiomics, based on T2-weighted MRI, can provide critical diagnostic information for discriminating between benign and borderline EOTs, thus having the potential to aid personalized treatment options. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-022-01264-x.
format Online
Article
Text
id pubmed-9363551
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-93635512022-08-11 T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study Wei, Mingxiang Zhang, Yu Bai, Genji Ding, Cong Xu, Haimin Dai, Yao Chen, Shuangqing Wang, Hong Insights Imaging Original Article BACKGROUND: Preoperative differentiation between benign and borderline epithelial ovarian tumors (EOTs) is challenging and can significantly impact clinical decision making. The purpose was to investigate whether radiomics based on T2-weighted MRI can discriminate between benign and borderline EOTs preoperatively. METHODS: A total of 417 patients (309, 78, and 30 samples in the training and internal and external validation sets) with pathologically proven benign and borderline EOTs were included in this multicenter study. In total, 1130 radiomics features were extracted from manually delineated tumor volumes of interest on images. The following three different models were constructed and evaluated: radiomics features only (radiomics model); clinical and radiological characteristics only (clinic-radiological model); and a combination of them all (combined model). The diagnostic performances of models were assessed using receiver operating characteristic (ROC) analysis, and area under the ROC curves (AUCs) were compared using the DeLong test. RESULTS: The best machine learning algorithm to distinguish borderline from benign EOTs was the logistic regression. The combined model achieved the best performance in discriminating between benign and borderline EOTs, with an AUC of 0.86 ± 0.07. The radiomics model showed a moderate AUC of 0.82 ± 0.07, outperforming the clinic-radiological model (AUC of 0.79 ± 0.06). In the external validation set, the combined model performed significantly better than the clinic-radiological model (AUCs of 0.86 vs. 0.63, p = 0.021 [DeLong test]). CONCLUSIONS: Radiomics, based on T2-weighted MRI, can provide critical diagnostic information for discriminating between benign and borderline EOTs, thus having the potential to aid personalized treatment options. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-022-01264-x. Springer Vienna 2022-08-09 /pmc/articles/PMC9363551/ /pubmed/35943620 http://dx.doi.org/10.1186/s13244-022-01264-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Wei, Mingxiang
Zhang, Yu
Bai, Genji
Ding, Cong
Xu, Haimin
Dai, Yao
Chen, Shuangqing
Wang, Hong
T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
title T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
title_full T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
title_fullStr T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
title_full_unstemmed T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
title_short T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
title_sort t2-weighted mri-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363551/
https://www.ncbi.nlm.nih.gov/pubmed/35943620
http://dx.doi.org/10.1186/s13244-022-01264-x
work_keys_str_mv AT weimingxiang t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy
AT zhangyu t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy
AT baigenji t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy
AT dingcong t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy
AT xuhaimin t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy
AT daiyao t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy
AT chenshuangqing t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy
AT wanghong t2weightedmribasedradiomicsfordiscriminatingbetweenbenignandborderlineepithelialovariantumorsamulticenterstudy